Medicared For All Logo

Jameel Uddeen in Manchester, Connecticut

Home Connecticut Manchester

Jameel Uddeen has Pulmonary Disease as his primary medical specialty. Their primary office is: 18 Haynes St in Manchester, Connecticut. There is an additional office location, for a total of two, for Jameel Uddeen that can be viewed further down.

They're a part of the: Prospect Ct Medical Foundation Inc medical group which has around 257 members. You can call their office at 860-649-7557 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2011 (around 13 years of experience). They are listed as doing telehealth appointments.


Jameel C Uddeen Office Phone and Directions

Jameel Uddeen
Prospect Ct Medical Foundation Inc
18 Haynes St
Manchester, Connecticut 06040
860-649-7557


Patient Ratings
Please rate your experience with Jameel Uddeen below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 860-649-7557


Enter a starting address:


Healthcare Info for Jameel Uddeen

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2011
The Primary Medical Specialty for Jameel Uddeen is listed as: Pulmonary Disease
Approximate Years of Experience: 13
PAC (PECOS ID)#: 1456662261
NPI #: 1669767059
NPI Created On: 06/14/2011
NPI Last Updated Listed as: 07/21/2022
Primary Taxonomy Code: 207R00000X
License Number:
54334
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Harvard Pilgrim Health Care Inc.
  • Medicare

They are listed as accepting new patients.


Services and Procedures include:

  1. Vaccine for influenza for injection into muscle
  2. Measurement and graphic recording of total and timed exhaled air capacity
  3. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  4. Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
  5. Determination of lung volumes using plethysmography
  6. Measurement of lung diffusing capacity
  7. Overnight measurement of oxygen saturation in blood using ear or finger device
  8. New patient office or other outpatient visit, typically 45 minutes
  9. Established patient office or other outpatient visit, typically 15 minutes
  10. Established patient office or other outpatient, visit typically 25 minutes
  11. Initial hospital inpatient care, typically 50 minutes per day
  12. Initial hospital inpatient care, typically 70 minutes per day
  13. Subsequent hospital inpatient care, typically 25 minutes per day
  14. Subsequent hospital inpatient care, typically 35 minutes per day
  15. Critical care delivery critically ill or injured patient, first 30-74 minutes
  16. Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes
  17. Physician telephone patient service, 5-10 minutes of medical discussion
  18. Physician telephone patient service, 11-20 minutes of medical discussion
  19. Administration of influenza virus vaccine
  20. Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788546351

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801731885

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802387329

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802547287

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802708917

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802740407

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802742063

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802871987

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $32

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802920407

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802921589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Additional Office Locations

1. Prospect Ct Medical Foundation Inc
170 Grandview Ave
Waterbury, CT 06708
Group Members: 257

Phone: 860-649-7557

Enter a starting address:


Pulmonary Disease Professionals in Manchester

18 Haynes St
Manchester, CT
Prospect Ct Medical Foundation Inc

18 Haynes St
Manchester, CT
Prospect Ct Medical Foundation Inc

515 Middle W Turnpike
Manchester, CT
Prohealth Physicians Pc

Providers in Prospect Ct Medical Foundation Inc

1.Medhat Abdelmessih

64 Robbins St
Waterbury Ct 06708-2613
Prospect Ct Medical Foundation Inc
Internal Medicine

2.Medhat Abdelmessih

160 Robbins St
Waterbury Ct 06708-2652
Prospect Ct Medical Foundation Inc
Internal Medicine

3.Momina Afrede

428 Hartford Tpke
Vernon Ct 06066-4841
Prospect Ct Medical Foundation Inc
Family Practice

4.Asma Afridi

175 W Rd
Ellington Ct 06029-3730
Prospect Ct Medical Foundation Inc
Family Practice

5.Muhammad Amjad

64 Robbins St
Waterbury Ct 06708-2613
Prospect Ct Medical Foundation Inc
Internal Medicine

6.Ehsan Ansari Md

64 Robbins St
Waterbury Ct 06708-2613
Prospect Ct Medical Foundation Inc
Cardiovascular Disease (cardiology)

View all 257 members of Prospect Ct Medical Foundation Inc medical group